HIV/AIDS News and Research

RSS
Home HIV-AIDS test could be a reality within two years

Home HIV-AIDS test could be a reality within two years

Researchers attack cervical cancer

Researchers attack cervical cancer

Pilgrimage to Mecca comes with a few medical risks

Pilgrimage to Mecca comes with a few medical risks

Major partnership with National Institute of Allergy and Infectious Diseases for Narhex Life Sciences

Major partnership with National Institute of Allergy and Infectious Diseases for Narhex Life Sciences

Important clue to understanding the origins of the AIDS epidemic

Important clue to understanding the origins of the AIDS epidemic

New portable infectious disease detector

New portable infectious disease detector

Important clue to understanding the origins of the AIDS epidemic

Important clue to understanding the origins of the AIDS epidemic

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Ranbaxy files anti-retrovirals (ARVs) to the U.S. FDA

Key genetic factor determines HIV/AIDS risk

Key genetic factor determines HIV/AIDS risk

Novel treatment promises to be an effective cure for tuberculosis

Novel treatment promises to be an effective cure for tuberculosis

Government should plough drug savings into Pharmaceutical Benefits Scheme (PBS)

Government should plough drug savings into Pharmaceutical Benefits Scheme (PBS)

Diagnosis of tuberculosis in young children can be confirmed by a straightforward sputum test

Diagnosis of tuberculosis in young children can be confirmed by a straightforward sputum test

Potential cure for lymphoma in HIV patients

Potential cure for lymphoma in HIV patients

Protein discovery with medical implications

Protein discovery with medical implications

Discovery could lead to a screening test that identifies people who have a higher or lower susceptibility to HIV/AIDS

Discovery could lead to a screening test that identifies people who have a higher or lower susceptibility to HIV/AIDS

DermaVir, a novel treatment for HIV/AIDS, complements and improves present drug therapies

DermaVir, a novel treatment for HIV/AIDS, complements and improves present drug therapies

States to explore putting restrictions on AIDS drug Trizivir

States to explore putting restrictions on AIDS drug Trizivir

PAHO dispels myths about the handling and the effects of mass casualties

PAHO dispels myths about the handling and the effects of mass casualties

New technique could lead to more effective therapies for AIDS

New technique could lead to more effective therapies for AIDS

Bio-Rad receives FDA approval for new HIV rapid test

Bio-Rad receives FDA approval for new HIV rapid test

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.